| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.9M | — | -42.6% |
| SG&A Expense | $2.8M | — | -35.9% |
| Operating Income | -$4.7M | — | +38.8% |
| Income Tax | $0 | — | — |
| Net Income | $15.3M | — | +385.2% |
| EPS (Basic) | $0.33 | — | +232.0% |
| EPS (Diluted) | -$0.04 | — | +84.0% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6K | -94.3% | -82.4% |
| Current Assets | $2.4M | -3.2% | +48.2% |
| Total Assets | $15.8M | -2.4% | -2.9% |
| Current Liabilities | $43.9M | -24.3% | +17.1% |
| Total Liabilities | $66.2M | -23.2% | -7.3% |
| Stockholders' Equity | -$50.3M |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | +30.6% |
| Investing Cash Flow | -$52K | — | -248.6% |
| Financing Cash Flow | $2.6M | — | -34.0% |
| +8.6% |